After 14 weeks on the HFD, WT mice developed hyperglycemia while deletion of PAI-1 was associated with fasting plasma glucose levels within the normal range (8.0 ± 0.3 vs. 12.3 ± 0.5 mM, p < 0.05). The gene discussed is SERPINE1; the disease is Hyperglycemia.